Table 1.
Demographic data, disease parameters, current clinical treatment, comorbidities, muscle strength, and pain in FM patients.
| Variable | Participants (n = 32) |
|---|---|
| Age (years) | 47.8 ± 13.7 |
| BMI (m/kg2) | 26.5 ± 3.1 |
| Time elapsed since diagnoses (years) | 9.4 ± 6.6 |
| Drugs: n (%) | |
| No drugs | 03/32 (9.3%) |
| Antidepressants | 21/32 (65.6%) |
| Analgesic | 11/32 (34.3%) |
| Muscular relaxant | 17/32 (53.1%) |
| NSAIDS | 05/32 (15.6%) |
| Opioids | 04/32 (12.5%) |
| Comorbidities: n (%) | |
| Osteoarthritis | 02/32 (6.2%) |
| Arterial hypertension | 09/32 (28.1%) |
| Dyslipidemia | 04/32 (12.5%) |
| Diabetes mellitus | 05/32 (16.6%) |
| Osteoporosis | 06/32 (18.7%) |
| Asthma | 01/32 (3.1%) |
| 1-RM Leg press (kg) | 144.5 ± 47.6 |
| 1-RM Bench press (kg) | 27.2 ± 6.3 |
| SF-MPQ pre | 22.6 ± 15.8 |
| VAS pre | 4.2 ± 2.7 |
Data expressed as mean ± SD or n (percentage of the sample). Abbreviations: (1-RM) 1-repetition maximum, (RPE) Rating of Perceived Exertion, (VAS) Visual Analogic Scale, (SF-MPQ) Short-Form McGill Pain Questionnaire.